Cargando…
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
We report a 69-year-old female patient with advanced lung cancer who developed myocarditis concomitant with myasthenia gravis (MG), also known as “Herzmyasthenie,” after 3 cycles of nivolumab administration. Her initial symptoms were general malaise and double vision. However, her myocarditis deteri...
Autores principales: | Fukasawa, Yoko, Sasaki, Kazuya, Natsume, Maika, Nakashima, Makoto, Ota, Shuji, Watanabe, Kiyotaka, Takahashi, Yoshihisa, Kondo, Fukuo, Kozuma, Ken, Seki, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649238/ https://www.ncbi.nlm.nih.gov/pubmed/29070994 http://dx.doi.org/10.1159/000479958 |
Ejemplares similares
-
Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021) -
Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management
por: Yanase, Takahiro, et al.
Publicado: (2020) -
Thymoma-Associated Myasthenia Gravis With Myocarditis
por: Sarwar, Shihab, et al.
Publicado: (2023) -
Relapsed Myasthenia Gravis after Nivolumab Treatment
por: Mitsune, Ayumi, et al.
Publicado: (2018) -
A rare case of nivolumab-related myasthenia gravis and myocarditis in a patient with metastatic gastric cancer
por: Komatsu, Masaru, et al.
Publicado: (2021)